Moderna 5. Mai 2026 Boston biotech firms back new effort to preserve U.S. edge in life sciences - The Business Journals
Moderna 4. Mai 2026 Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues - Fierce Biotech
Moderna 4. Mai 2026 Biopharma bites: Tolerability sinks Vertex-Moderna's CF candidate, Takeda's immune win, and more from Amgen, Latus - FirstWord Pharma
Moderna 1. Mai 2026 Moderna sees revenue bump from international COVID vaccine sales - BioPharma Dive
Moderna 30. Apr. 2026 Moderna loses key mRNA patent in European vaccine fight - Life Sciences Intellectual Property Review
Moderna 28. Apr. 2026 Moderna Deploys Salesforce Agentforce Life Sciences to Unify Global Commercial Operations - HIT Consultant
Moderna 28. Apr. 2026 CureVac targets Moderna with 10-patent suit over Spikevax - Life Sciences Intellectual Property Review
Moderna 22. Apr. 2026 Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial - BioPharma Dive
Moderna 22. Apr. 2026 Moderna launches mRNA bird flu vaccine trial after HHS cancels funding - The Washington Post
Moderna 21. Apr. 2026 Moderna | History, Innovation, Challenges, & Facts | Britannica Money - Britannica
Moderna 23. Jan. 2026 Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials - Fierce Biotech